HomeNDC LookupRxCUI directory › RxCUI 243670

Aspirin 81 MG Oral Tablet — RxCUI 243670

RxNorm drug concept · Semantic clinical drug
RxCUI 243670 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 5 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI243670
Official nameAspirin 81 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asASA 81 MG Oral Tablet
FDA products mapped2
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Aspirin Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. A rectal suppository gets the medication into your system through the lining of the rectum rather than your stomach. This can be helpful if you're having trouble sw...
  • Why would someone use a rectal suppository instead of just taking aspirin by mouth?
  • First, check that the foil or plastic packet is fully sealed and undamaged before you open it — don't use it if it looks like it's already been opened. Once you open it, insert the...
  • This is really important: aspirin — including the suppository form — should NOT be given to children or teenagers who have or are recovering from chicken pox or the flu. There is a...
📖 Read our full Aspirin Rectal guide →

🕸️ Concept Web — How Aspirin 81 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Aspirin 81 MG Oral Tablet RxCUI 243670

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Aspirin 1191
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Anacin Aspirin Regimen 724441
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Aspirin Oral Tablet 370611
    • Aspirin Oral Product 1154069
    • Aspirin Pill 1154070
    • Aspirin Oral Tablet [Anacin Aspirin Regimen] 724443
    • Anacin Aspirin Regimen Oral Product 1174228
    • Anacin Aspirin Regimen Pill 1174229
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Aspirin 81 MG 315431
    • Aspirin 81 MG Oral Tablet [Anacin Aspirin Regimen] 724444
    • Aspirin 81 MG [Anacin Aspirin Regimen] 724442
  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

    • {30 (aspirin 81 MG Oral Tablet) / 30 (pravastatin sodium 40 MG Oral Tablet) } Pack 904668

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Aspirin 81 MG SCDC · 315431
  • Aspirin Oral Tablet SCDF · 370611
  • Aspirin Oral Product SCDG · 1154069
  • Aspirin Pill SCDG · 1154070
  • {30 (aspirin 81 MG Oral Tablet) / 30 (pravastatin sodium 40 MG Oral Tablet) } Pack GPCK · 904668

Brand-Name Concepts

  • Aspirin 81 MG Oral Tablet [Anacin Aspirin Regimen] SBD · 724444
  • Aspirin 81 MG [Anacin Aspirin Regimen] SBDC · 724442
  • Aspirin Oral Tablet [Anacin Aspirin Regimen] SBDF · 724443
  • Anacin Aspirin Regimen Oral Product SBDG · 1174228
  • Anacin Aspirin Regimen Pill SBDG · 1174229
  • Anacin Aspirin Regimen BN · 724441

📦 FDA Products & Package NDCs

2 products · 5 package NDCs
5 package NDCs map to RxCUI 243670 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
21130-0481-12 1 BOTTLE in 1 CARTON (21130-481-12) / 120 TABLET in 1 BOTTL... Low dose aspirin 81mg BETTER LIVING BRANDS LLC. 2023-07-14
21130-0481-20 1 BOTTLE in 1 CARTON (21130-481-20) / 200 TABLET in 1 BOTTL... Low dose aspirin 81mg BETTER LIVING BRANDS LLC. 2023-07-14
21130-0481-32 1 BOTTLE in 1 CARTON (21130-481-32) / 32 TABLET in 1 BOTTLE Low dose aspirin 81mg BETTER LIVING BRANDS LLC. 2023-07-14
21130-0481-50 500 TABLET in 1 BOTTLE (21130-481-50) Low dose aspirin 81mg BETTER LIVING BRANDS LLC. 2023-07-14
84324-0017-01 300 TABLET in 1 BOTTLE (84324-017-01) Aspirin Low Dose NUVICARE LLC 2024-08-01
Observed labelers: BETTER LIVING BRANDS LLC. (4) · NUVICARE LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.